BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32101157)

  • 1. The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery.
    Demyanets S; Kaun C; Kaider A; Speidl W; Prager M; Oravec S; Hohensinner P; Wojta J; Rega-Kaun G
    Cardiovasc Diabetol; 2020 Feb; 19(1):26. PubMed ID: 32101157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of bariatric surgery on liver glucose metabolism in morbidly obese diabetic and non-diabetic patients.
    Immonen H; Hannukainen JC; Iozzo P; Soinio M; Salminen P; Saunavaara V; Borra R; Parkkola R; Mari A; Lehtimäki T; Pham T; Laine J; Kärjä V; Pihlajamäki J; Nelimarkka L; Nuutila P
    J Hepatol; 2014 Feb; 60(2):377-83. PubMed ID: 24060855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roux-en-Y-Bariatric Surgery Reduces Markers of Metabolic Syndrome in Morbidly Obese Patients.
    Rega-Kaun G; Kaun C; Jaegersberger G; Prager M; Hackl M; Demyanets S; Wojta J; Hohensinner PJ
    Obes Surg; 2020 Feb; 30(2):391-400. PubMed ID: 31728904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery.
    Miller GD; Nicklas BJ; Fernandez A
    Surg Obes Relat Dis; 2011; 7(5):618-24. PubMed ID: 21546319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of circulating proinflammatory marker, leucine-rich-α2-glycoprotein (LRG1), following metabolic/bariatric surgery.
    Pek SLT; Cheng AKS; Lin MX; Wong MS; Chan EZL; Moh AMC; Sum CF; Lim SC; Tavintharan S
    Diabetes Metab Res Rev; 2018 Oct; 34(7):e3029. PubMed ID: 29883055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the biochemical, inflammatory and oxidative profile of obese patients given clinical treatment and bariatric surgery.
    Schmatz R; Bitencourt MR; Patias LD; Beck M; da C Alvarez G; Zanini D; Gutierres JM; Diehl LN; Pereira LB; Leal CA; Duarte MF; Schetinger MR; Morsch VM
    Clin Chim Acta; 2017 Feb; 465():72-79. PubMed ID: 27986549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Soluble ST2 as a Novel Inflammatory Marker in Acute Ischemic Stroke.
    Chen W; Lin A; Yu Y; Zhang L; Yang G; Hu H; Luo Y
    Clin Lab; 2018 Sep; 64(9):1349-1356. PubMed ID: 30274001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity.
    Kjellmo CA; Karlsson H; Nestvold TK; Ljunggren S; Cederbrant K; Marcusson-Ståhl M; Mathisen M; Lappegård KT; Hovland A
    J Clin Lipidol; 2018; 12(1):193-202. PubMed ID: 29146227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can bariatric surgery improve cardiovascular risk factors in the metabolically healthy but morbidly obese patient?
    Goday A; Benaiges D; Parri A; Ramón JM; Flores-Le Roux JA; Pedro Botet J;
    Surg Obes Relat Dis; 2014; 10(5):871-6. PubMed ID: 25282193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bariatric surgery in morbidly obese patients improves the atherogenic qualitative properties of the plasma lipoproteins.
    Julve J; Pardina E; Pérez-Cuéllar M; Ferrer R; Rossell J; Baena-Fustegueras JA; Fort JM; Lecube A; Blanco-Vaca F; Sánchez-Quesada JL; Peinado-Onsurbe J
    Atherosclerosis; 2014 May; 234(1):200-5. PubMed ID: 24674904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery.
    Baena-Fustegueras JA; Pardina E; Balada E; Ferrer R; Catalán R; Rivero J; Casals I; Lecube A; Fort JM; Vargas V; Peinado-Onsurbe J
    JAMA Surg; 2013 Feb; 148(2):151-6. PubMed ID: 23426590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum sST2 and sCD40L values in patients with microvascular angina.
    Aslan G; Polat V; Bozcali E; Opan S; Çetin N; Ural D
    Microvasc Res; 2019 Mar; 122():85-93. PubMed ID: 30502363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-33/suppression of tumorigenicity 2 (IL-33/ST2) axis in idiopathic inflammatory myopathies and its association with laboratory and clinical parameters: a pilot study.
    Opinc A; Sarnik J; Brzezińska O; Makowski M; Lewandowska-Polak A; Makowska J
    Rheumatol Int; 2020 Jul; 40(7):1133-1141. PubMed ID: 32222805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevations in Circulating sST2 Levels Are Associated With In-Hospital Mortality and Adverse Clinical Outcomes After Blunt Trauma.
    Billiar IM; Guardado J; Abdul-Malak O; Vodovotz Y; Billiar TR; Namas RA
    J Surg Res; 2019 Dec; 244():23-33. PubMed ID: 31279260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure.
    Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q
    Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum levels of IL-33 and soluble ST2 in neonates with human cytomegalovirus infection.
    Chen Y; Qian J
    J Med Virol; 2018 Aug; 90(8):1383-1388. PubMed ID: 29663450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial changes on plasma apolipoproteins A and B, high density lipoproteins and oxidized low density lipoproteins in obese women after bariatric surgery: comparison between gastric bypass and sleeve gastrectomy.
    Gómez-Martin JM; Balsa JA; Aracil E; Cuadrado-Ayuso M; Rosillo M; De la Peña G; Lasunción MA; Escobar-Morreale HF; Botella-Carretero JI
    Lipids Health Dis; 2018 Jun; 17(1):145. PubMed ID: 29925393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of soluble ST2, but not IL-33, correlate with the severity of alcoholic liver disease.
    Sun Z; Chang B; Huang A; Hao S; Gao M; Sun Y; Shi M; Jin L; Zhang W; Zhao J; Teng G; Han L; Tian H; Liang Q; Zhang JY; Zou Z
    J Cell Mol Med; 2019 Feb; 23(2):887-897. PubMed ID: 30478965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ghrelin and apolipoprotein AIV levels show opposite trends to leptin levels during weight loss in morbidly obese patients.
    Pardina E; López-Tejero MD; Llamas R; Catalán R; Galard R; Allende H; Vargas V; Lecube A; Fort JM; Baena-Fustegueras JA; Peinado-Onsurbe J
    Obes Surg; 2009 Oct; 19(10):1414-23. PubMed ID: 19172368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved metabolism and body composition beyond normal levels following gastric bypass surgery: a longitudinal study.
    Andersson DP; Dahlman I; Eriksson Hogling D; Bäckdahl J; Toft E; Qvisth V; Näslund E; Thorell A; Rydén M; Arner P
    J Intern Med; 2019 Jan; 285(1):92-101. PubMed ID: 30141528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.